Dr. Boto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2800 Main St
Bridgeport, CT 06606Phone+1 475-210-5032Fax+1 475-210-5034
Education & Training
- Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 2012 - 2016
- Johns Hopkins University School of MedicineClass of 2012
Certifications & Licensure
- MD State Medical License 2023 - 2026
- VA State Medical License 2023 - 2026
- CT State Medical License 2016 - 2025
- NJ State Medical License 2023 - 2025
- NY State Medical License 2018 - 2025
- DC State Medical License 2023 - 2024
- PA State Medical License 2014 - 2016
- American Board of Pathology Pathology - Anatomic
Publications & Presentations
PubMed
- An Uncommon Presentation of Carcinosarcoma of the Stomach and a Minimally Invasive Approach for Treatment.Anoush Calikyan, Agedi N Boto, Valeriia Klymenko, Imran M Siddiqui
Case Reports in Gastrointestinal Medicine. 2022-01-01 - 78 citationsPD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus.Xue Han, Matthew D. Vesely, Wendy Yang, Miguel F. Sanmamed, Ti Badri
Science Translational Medicine. 2019-12-11 - 418 citationsSiglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy.Jun Wang, Jingwei Sun, Linda N. Liu, Dallas B. Flies, Xinxin Nie
Nature Medicine. 2019-03-04
Journal Articles
- Siglec-15 as an Immune Suppressor and Potential Target for Normalization Cancer ImmunotherapyDavid L Rimm, Agedi N Boto, Roy S Herbst, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: